SPOTLIGHT: Boehringer launch aided by charity

Boehringer Ingelheim launched its blood thinner Pradaxa last week, getting a media boost from the backing of Lifeblood, a charity that's been lobbying for changes to the National Institute for Clinical Excellence's thrombosis treatment guidelines. Release | Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.